Markets:

Overview

News

Currencies

International

Treasuries

Arm Holdings plc - American Depositary Shares (NQ:ARM)

241.56 UNCHANGED

Streaming Delayed Price Updated: 4:00 PM EDT, Aug 25, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about Arm Holdings plc - American Depositary Shares

< Previous 1 2 3 4 5 6 7 8 9

...

97 98 Next >

Church & Dwight EVP Sells 15,375 Shares for $1.6 Million -- Should Investors Beware? ↗

Today 7:17 EDT

Carlos Linares exercised options at $50.28 per share and immediately sold at $102.00, maintaining his total beneficial ownership through the same-day conversion of derivative securities.

Via The Motley Fool

Topics Regulatory Compliance

Billionaire David Tepper Sold Every Single Share of UnitedHealth in Q2. Here's Whether He Made a Costly Mistake. ↗

Today 6:50 EDT

UnitedHealth still looks like a compelling long-term investment.

Via The Motley Fool

Topics Artificial Intelligence Economy

GenAI Org Chart Reveal Paramount's Games Studio Shift, Here Is How It Works ↗

Today 6:12 EDT

Selling rendering software or IP licenses to a legacy studio used to follow a predictable script.Vendors targeted the VP of Interactive.Pitched a standalon

Via Talk Markets

The Market Has Priced Intel Anywhere Between $24 and $142 in the Past 12 Months ↗

Today 4:12 EDT

A six-fold spread inside a single year. How much of the price is the business, and how much is the promise?

Via The Motley Fool

Topics Artificial Intelligence

Brazilian Jiu Jitsu Orlando – Learn Practical Grappling Skills ↗

August 25, 2026

You do not have to be the strongest person in the room to become effective at grappling. Brazilian Jiu Jitsu is built around leverage, positioning, timing,

Via Talk Markets

Jazz Pharmaceuticals Launches Ziihera After FDA Nod in HER2-Positive GEA ↗

August 25, 2026

Jazz Pharmaceuticals (NASDAQ:JAZZ) outlined its plans for the U.S. launch of Ziihera following FDA approval of the therapy for first-line HER2-positive unresectable, locally advanced or metastatic...

Via MarketBeat

Topics Cannabis

IBM Just Opened Its Mainframes to Arm—Is the Market Missing the Shift? ↗

August 25, 2026

IBM is integrating ARM Holdings' architecture into its mainframes, enabling native dual-execution without emulation, as shares trade near $231 amid a 22% year-to-date decline.

Via MarketBeat

Topics Artificial Intelligence

2 Tech Stocks I'd Load Up on Today and 1 I'd Avoid Until Further Notice ↗

August 25, 2026

Two don't need to be second-guessed, while the other is built more on long-term promises.

Via The Motley Fool

Topics Stocks

Prediction: SoundHound AI Stock Could Be Worth $20 in 2030. Here’s the Math ↗

August 25, 2026

SoundHound AI stock could recover nicely by 2030, driven by the company's solid growth and the opportunity in the conversational AI market.

Via The Motley Fool

Topics Artificial Intelligence Earnings

Warren Buffett Continues to Load Up on Alphabet, and This 1 Number Is the Big Reason Why ↗

August 25, 2026

Buffett's newfound love for Alphabet rests on one number buried deep in Alphabet's financial reports.

Via The Motley Fool

Topics Artificial Intelligence

ExxonMobil Is Eyeing a Potential $8 Billion Bet on Shell's U.S. Chemical Plants. Here's What It Means for XOM Stock. ↗

August 24, 2026

Shell is looking to unload its U.S. chemicals assets.

Via The Motley Fool

FAAC Gate Barrier: A Smart Solution for Vehicle Access Control ↗

August 24, 2026

Modern facilities require reliable systems to manage vehicle movement, improve security, and maintain smooth traffic flow. A FAAC gate barrier is an advanc

Via Talk Markets

UPS Stopped Carrying 2 Million Amazon Packages a Day. Amazon Still Has to Move Them. ↗

August 23, 2026

The 18-month handoff is complete -- and by volume, America's biggest parcel carrier is now the retailer, not the traditional carriers.

Via The Motley Fool

Topics Earnings

How to Choose the Perfect Shirt for Every Occasion ↗

August 23, 2026

A well-chosen shirt can transform an everyday outfit into something polished, comfortable, and confident. Whether you are dressing for work, a family gathe

Via Talk Markets

Boom Barrier Systems: A Smarter Approach to Vehicle Access Control in Saudi Arabia ↗

August 22, 2026

IntroductionA boom barrier offers an efficient solution for regulating vehicle entry and exit points while maintaining smooth traffic flow. These automated

Via Talk Markets

Prediction: This Artificial Intelligence (AI) Semiconductor Stock Will Outperform Nvidia Over the Next 3 Years ↗

August 22, 2026

AMD looks poised to outperform Nvidia over the next three years.

Via The Motley Fool

Topics Artificial Intelligence

Why BitMine Immersion Technologies Stock Skyrocketed by 26% This Week ↗

August 21, 2026

Generally speaking, as cryptos go, so goes the company's equity.

Via The Motley Fool

Topics Bonds Government

Advanced Micro Devices vs. Arm Holdings: Comparing Revenue Trends Between These Artificial Intelligence Companies ↗

August 21, 2026

Via The Motley Fool

Topics Artificial Intelligence

Prediction: Nvidia Stock Will Go Parabolic After Aug. 26. Here Are 2.3 Trillion Reasons Why ↗

August 21, 2026

The huge revenue backlogs of major U.S. hyperscalers could help Nvidia crush expectations when it releases its quarterly results.

Via The Motley Fool

Topics Artificial Intelligence Earnings

The History of Indian Bronze Sculptures ↗

August 21, 2026

Bronze sculpture is one of India's oldest and most beautiful art forms. For thousands of years, Indian artists have used bronze to create images of gods, g

Via Talk Markets

Pantograph Charger Market: A Deep Dive into Regional Trends ↗

August 20, 2026

Electric buses don't have time to sit around waiting for a slow charge — and that's exactly the problem pantograph chargers were built to solve. By droppin

Via Talk Markets

Topics Electric Vehicles

How to Prevent Sports Injuries During Exercise ↗

August 20, 2026

Exercise is one of the best ways to improve strength, flexibility, endurance, and overall health. Whether you enjoy running, weight training, cycling, swim

Via Talk Markets

What Makes a Reliable Rear Windshield Wiper for KIA Vehicles? ↗

August 20, 2026

Quick Q&AQ: What makes a rear windshield wiper reliable for KIA vehicles?A: A reliable rear wiper for KIA models comes down to accurate model-specific fitm

Via Talk Markets

Allogene (ALLO) Q2 2026 Earnings Call Transcript ↗

August 19, 2026

Cema-cel hit 58.3% MRD negativity in ALPHA3 with zero treatment hospitalizations.

Via The Motley Fool

Topics Earnings

How Morgan Stanley Turned the SpaceX IPO Into a Money Machine ↗

August 19, 2026

When a company like SpaceX goes public, most people think about the headline event: a huge valuation, a stock ticker etc., what doesn't get talked about as

Via Talk Markets

Topics Artificial Intelligence Initial Public Offering

Why Chassis Parts Are Becoming a Strategic Category in the Global Automotive Aftermarket ↗

August 19, 2026

The automotive aftermarket is often viewed through the most visible categories: engine components, brake systems, batteries, tires, and routine maintenance

Via Talk Markets

Topics Supply Chain

Stoke Therapeutics’ Dravet Trial Tops Enrollment Target With Zero Dropouts ↗

August 17, 2026

Stoke Therapeutics (NASDAQ:STOK) said its Phase III EMPEROR study of zorevunersen for Dravet syndrome has enrolled 162 patients, exceeding its target enrollment of 150, with no patient discontinuations...

Via MarketBeat

EyePoint’s DURAVYU Misses Primary Endpoint in Phase III Wet AMD Trial ↗

August 17, 2026

Eyepoint Pharmaceuticals (NASDAQ:EYPT) reported topline results from LUGANO, the first of two Phase III trials evaluating DURAVYU, a vorolanib intravitreal insert, in patients with wet age-related...

Via MarketBeat

RTX, Pentagon Sign $23 Billion Tomahawk Missile Contract ↗

August 17, 2026

The Department of Defense has been pushing contractors to ramp up production of critical munitions. RTX stock rose about 1% on Monday.

Via Investor's Business Daily

argenx VYVGART Hits Phase III Goal in Autoimmune Myositis, Eyes IMNM Filing ↗

August 17, 2026

argenx (NASDAQ:ARGX) reported positive top-line results from its Phase III ALKIVIA trial of VYVGART Hytrulo in autoimmune myositis, meeting its primary endpoint in a combined population of patients...

Via MarketBeat

Topics Intellectual Property

< Previous 1 2 3 4 5 6 7 8 9

...

97 98 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.